EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Long‐Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10‐Year Follow‐Up

Patricia Krause iD, Philipp Mahlknecht iD, Inger Marie Skogseid, Frank Steigerwald iD, Günther Deuschl iD, Richard Erasmi, Alfons Schnitzler, Tobias Warnecke, Jörg Müller, Werner Poewe, Gerd-Helge Schneider, Jan Vesper und 7 weitere

Movement Disorders · 2025

DOI: 10.1002/mds.30130 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift Movement Disorders, 2025. Verfasst von Patricia Krause und 18 weiteren Autor:innen. Beteiligte Einrichtung: Movement Disorder and Neuromodulation Unit, Charité, University Medicine Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Dystonia, Globus Pallidus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pallidal neurostimulation is an effective treatment for severe isolated dystonia, but long‐term data from clinical trials are lacking.

Objectives

To evaluate long‐term efficacy and safety of pallidal neurostimulation in patients with isolated generalized or segmental dystonia.

Methods

Extension study of the prospective multicenter trial (n = 40; July 2002 to May 2004), all patients received effective stimulation and underwent regular follow‐up. The 10‐year follow‐up (n = 31) included Burke–Fahn–Marsden Dystonia Rating Scale (BFMDRS) motor and disability score, Beck Depression Inventory, Beck Anxiety Inventory, and Mattis Dementia Rating Scale. Primary and secondary endpoints compared motor symptoms, disability scores, mood, and cognition changes.

Results

Thirty‐one patients (12 female), aged 23–72 years, completed the 10‐year study extension. Per protocol analysis showed sustained significant improvement in BFMDRS motor scores at 10 years compared with baseline, without significant change from the 6‐month or 5‐year follow‐up. On average, motor scores decreased by 25.3 ± 5.2 points at 10 years ( P < 0.0001; 56% improvement). Individual outcomes varied, with 27 responders (≥25% improvement; mean improvement 65.2 ± 21.4%) and 13 non‐responders compared with baseline. Sustained improvements were seen in disability, mood, and anxiety scores. Cognition remained stable.

Conclusions

This study presents the longest prospective, multicenter follow‐up of pallidal neurostimulation in generalized and segmental dystonia. Two‐thirds of patients showed strong and stable long‐term improvements of dystonia, confirming sustained efficacy and safety over 10 years in treatment‐refractory dystonic patients. However, one‐third experienced primary (3/40) or secondary (10/40) treatment failure. Diagnostic advances, including genetic testing, and technological progress in pallidal neurostimulation may help to reduce the non‐responder rates in the future. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep Brain StimulationDystoniaGlobus PallidusAdultAgedFemaleHumansMaleMiddle AgedYoung AdultFollow-Up StudiesProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

DBS responsedeep brain stimulationdystonialong‐term follow‐upneurostimulation

Autor:innen und Institutionen

  • Movement Disorder and Neuromodulation Unit, Charité, University Medicine Berlin, Berlin, Germany.
  • Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
  • Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Department of Neurology, University of Würzburg, Würzburg, Germany.
  • Department of Neurology, Christian-Albrechts-University, Kiel, Germany.
  • Institute of Clinical Neuroscience and Medical Psychology, and Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.

ORCID-Profile: Patricia Krause, Philipp Mahlknecht, Frank Steigerwald, Günther Deuschl

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Krause, P., Mahlknecht, P., Skogseid, I. M., Steigerwald, F., Deuschl, G., Erasmi, R., Schnitzler, A., Warnecke, T., Müller, J., Poewe, W., Schneider, G. H., Vesper, J., Warneke, N., Eisner, W., Prokop, T., Müller, J. U., Volkmann, J., Kühn, A. A., & Deep‐Brain Stimulation for Dystonia Study Group (2025). Long‐Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10‐Year Follow‐Up. Movement Disorders. https://doi.org/10.1002/mds.30130

Vancouver

Krause P, Mahlknecht P, Skogseid IM, Steigerwald F, Deuschl G, Erasmi R, et al. Long‐Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10‐Year Follow‐Up. Movement Disorders. 2025. doi:10.1002/mds.30130

BibTeX
@article{Krause2025,
  author = {Krause, Patricia and Mahlknecht, Philipp and Skogseid, Inger Marie and Steigerwald, Frank and Deuschl, Günther and Erasmi, Richard and Schnitzler, Alfons and Warnecke, Tobias and Müller, Jörg and Poewe, Werner and Schneider, Gerd-Helge and Vesper, Jan and Warneke, Nils and Eisner, Wilhelm and Prokop, Thomas and Müller, Jan-Uwe and Volkmann, Jens and Kühn, Andrea A and Deep‐Brain Stimulation for Dystonia Study Group, Deep‐Brain Stimulation for Dystonia Study Group},
  title = {Long‐Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10‐Year Follow‐Up},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.30130}
}
Kostenlos starten →